Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Questcor Pharmaceuticals makes appointments

This article was originally published in Scrip

Executive Summary

Questcor Pharmaceuticals (US) has appointed Dr David Young, currently a member of the company's board of directors, to the newly created position of chief scientific officer, and has appointed Dr Sian Bigora to the newly created position of vice-president of regulatory affairs. Dr Young joins Questcor from AGI Therapeutics, where he had served as executive director and president of US operations since 2006. Dr Bigora also joins from AGI Therapeutics, where she was vice-president of clinical research and regulatory affairs. Both executives will be based at the company's new east coast offices in Columbia, Maryland.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts